108 related articles for article (PubMed ID: 9504188)
1. Hormonal-induced changes on the lipid composition and DPH fluorescence anisotropy of erythrocyte ghost from pre- and postmenopausal women.
Marra CA; Mangionil JO; Tavella M; del Alaniz MJ; Ortiz D; Sala C
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(1):8-17. PubMed ID: 9504188
[TBL] [Abstract][Full Text] [Related]
2. Dietary fat and hormonal effects on erythrocyte membrane fluidity and lipid composition in adult women.
Berlin E; Bhathena SJ; Judd JT; Nair PP; Jones DY; Taylor PR
Metabolism; 1989 Aug; 38(8):790-6. PubMed ID: 2761416
[TBL] [Abstract][Full Text] [Related]
3. Dietary and metabolic differences in pre- versus postmenopausal women taking or not taking hormone replacement therapy.
Reimer RA; Debert CT; House JL; Poulin MJ
Physiol Behav; 2005 Feb; 84(2):303-12. PubMed ID: 15708782
[TBL] [Abstract][Full Text] [Related]
4. Lower levels of prepulse inhibition in luteal phase cycling women in comparison with postmenopausal women.
Bannbers E; Kask K; Wikström J; Sundström Poromaa I
Psychoneuroendocrinology; 2010 Apr; 35(3):422-9. PubMed ID: 19735984
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy.
Stark KD; Park EJ; Holub BJ
Menopause; 2003; 10(5):448-55. PubMed ID: 14501607
[TBL] [Abstract][Full Text] [Related]
6. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
7. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
8. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
9. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
[TBL] [Abstract][Full Text] [Related]
10. Beta-estradiol effect on erythrocyte aggregation--a controlled in vitro study.
Gonçalves I; Saldanha C; Martins e Silva J
Clin Hemorheol Microcirc; 2001; 25(3-4):127-34. PubMed ID: 11847415
[TBL] [Abstract][Full Text] [Related]
11. [Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women].
Zhou YZ; Jiang YX; Sun Q; Zhang SQ; Zhang Y; Chen FL; Lin SQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):609-13. PubMed ID: 12901108
[TBL] [Abstract][Full Text] [Related]
12. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
13. The effect of maternal ethanol intoxication on erythrocyte ghost fluidity in new-born rat pups.
Arienti G; Battistoni F; Carlini E; Di Renzo GC; Cosmi EV; Reboldi GP
Biochem Mol Biol Int; 1994 May; 33(1):1-8. PubMed ID: 8081199
[TBL] [Abstract][Full Text] [Related]
14. Estradiol, progesterone and plasma lipids during the menstrual cycle.
Basdevant A; De Lignieres B; Bigorie B; Guy-Grand B
Diabete Metab; 1981 Mar; 7(1):1-4. PubMed ID: 7238973
[TBL] [Abstract][Full Text] [Related]
15. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
Alfonso Cano C; Vez García MD; García Urruticoechea P; Tornel Osorio PL; Canteras Jordana M; Abellán Alemán J
An Med Interna; 2003 Feb; 20(2):70-4. PubMed ID: 12703158
[TBL] [Abstract][Full Text] [Related]
16. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
Conner P; Skoog L; Söderqvist G
Climacteric; 2001 Mar; 4(1):7-12. PubMed ID: 11379380
[TBL] [Abstract][Full Text] [Related]
17. Effects of pre- and postmenopausal use of exogenous hormones on receptor content in normal human breast tissue: a randomized study.
Hallberg G; Persson I; Naessén T; Magnusson C
Gynecol Endocrinol; 2008 Aug; 24(8):475-80. PubMed ID: 18850387
[TBL] [Abstract][Full Text] [Related]
18. Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients.
Nikolić-Vukosavljević D; Vasiljević N; Branković-Magić M; Polić D
Neoplasma; 1996; 43(3):163-9. PubMed ID: 8841503
[TBL] [Abstract][Full Text] [Related]
19. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
20. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
